AstraZeneca and Huma Partner to Accelerate Innovation for Digital-First Patient Care

Huma Therapeutics Limited, a digital health technology company has announced partnership with AstraZeneca for the purpose of scaling the innovation of digital health. This partnership has been following the prior use cases have been executed between AstraZeneca and Huma has been reflecting a shared ambition for the purpose of improving the clinical outcomes through the […]

Continue Reading

UK MHRA Approves Antibody Cocktail for Covid-19 by AstraZeneca

The UK MHRA (Medicines and Healthcare products Regulatory Agency) has now granted the authorization to the Evusheld of AstraZeneca for the pre-exposure prophylaxis (PrEP) against the novel corona virus, and the Evusheld has been a cocktail of the two monoclonal long-acting antibodies, along with the cilgavimab and tixagevimab. The company ‘AstraZeneca’ has now licensed the […]

Continue Reading